v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 73,881 $ 92,074 $ 240,984 $ 288,840
General and administrative 18,543 22,919 66,746 73,314
Total operating expenses 92,424 114,993 307,730 362,154
Loss from operations (92,424) (114,993) (307,730) (362,154)
Other income (expense):        
Interest expense (451) (503) (1,395) (1,547)
Interest income 8,066 9,997 25,311 28,706
Other income 427 876 593 1,244
Loss before income taxes (84,382) (104,623) (283,221) (333,751)
Income tax provision (95) (1,201) (295) (1,194)
Net loss (84,477) (105,824) (283,516) (334,945)
Other comprehensive income (loss):        
Unrealized gain (loss) on marketable securities (1,095) 656 (2,733) 115
Total comprehensive loss $ (85,572) $ (105,168) $ (286,249) $ (334,830)
Net loss per share - Basic $ (0.14) $ (0.18) $ (0.46) $ (0.59)
Net loss per share - Diluted $ (0.14) $ (0.18) $ (0.46) $ (0.59)
Weighted-average common shares outstanding - Basic 620,557 588,728 616,251 566,293
Weighted-average common shares outstanding - Diluted 620,557 588,728 616,251 566,293